kaiser and semaglutide A Closer Look: GLP-1 Medications for Weight Loss | Permanente Kaiser Family Foundation - Sludge

Originally developed to manage diabetes, Semaglutide has quickly become recognized for its ability to effectively facilitate weight loss

The most common adverse effects associated with therapeutic semaglutide use include gastrointestinal symptoms, which might theoretically occur more rapidly or intensely with direct venous administration

Researchers who hit a plateau between weeks 33 and 52 have several evidence-based options

Inconsistent injection timing, inadequate calorie reduction, high refined-carbohydrate intake, poor sleep, and low physical activity can slow progress

After that, eligibility is based mainly on body weight and health status